HIG Capital Raising Bio-Focused Venture Fund
Florida-based H.I.G. Ventures is in the market with a new venture capital fund focused exclusively on life sciences companies. The firm had allocated around half of its $300 million second fund to life sciences investing, according to managing director Aaron Davidson, but now feels that the strategy deserves a dedicated vehicle. The fund will focus primarily on companies developing therapeutic drugs or medical devices across sectors and stages, Davidson said. Specifically, “capital efficient businesses with large market opportunities in underserved geographies, and products with shorter development.”
2 February 2010•2 mins read
